Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.

A recent Executive Order (EO) de-risks psychedelic drug development by clarifying regulations, but scalable treatment models ...

The FDA is holding a public hearing to talk through psychedelic drug development on 14 September.

Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of ...

The study uncovered how the psychedelic drug DOI reduces anxiety by activating particular neurons in the brain. DOI’s anxiety-reducing properties do not coincide with its hallucinogenic effects, ...

Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels. In 2023, ...

A new study suggests that virtual reality experiences designed to mimic psychedelic visual effects could safely boost creativity and flexibility in thinking -- without the use of drugs. Researchers ...

The psychedelic effects recreational users often seek from taking ketamine do not predict the therapeutic benefits for people being treated for alcohol use disorder. The popular theory, which says ...